Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.

    Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE.

    Gastroenterology. 2006 Sep;131(3):729-37.PMID: 16952542 [PubMed - indexed for MEDLINE]Related articles

    2.

    Thymidylate synthase expression in colon carcinomas with microsatellite instability.

    Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN.

    Clin Cancer Res. 2006 May 1;12(9):2738-44.PMID: 16675565 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot.

    Sloan JA, Sargent DJ, Lindman J, Allmer C, Vargas-Chanes D, Creagan ET, Bonner JA, O'Connell MJ, Dalton RJ, Rowland KM, Brooks BJ, Laurie JA.

    Qual Life Res. 2002 Feb;11(1):37-45.PMID: 12003054 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

    O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figueredo A.

    J Clin Oncol. 1998 Jan;16(1):295-300.PMID: 9440756 [PubMed - indexed for MEDLINE]Related articles

    6.

    An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.

    Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA.

    Oncology. 1997 Jul-Aug;54(4):287-92.PMID: 9216852 [PubMed - indexed for MEDLINE]Related articles

    7.

    Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.

    Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD.

    Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):345-9.PMID: 8892458 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al.

    J Clin Oncol. 1995 Dec;13(12):2936-43.PMID: 8523058 [PubMed - indexed for MEDLINE]Related articles

    9.

    Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.

    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA.

    Ann Intern Med. 1995 Mar 1;122(5):321-6.PMID: 7847642 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

    Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, et al.

    J Clin Oncol. 1994 Mar;12(3):601-7.PMID: 8120560 [PubMed - indexed for MEDLINE]Related articles

    11.

    Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.

    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA.

    J Clin Oncol. 1993 Dec;11(12):2386-90.PMID: 8246027 [PubMed - indexed for MEDLINE]Related articles

    12.

    An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.

    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C.

    JAMA. 1993 Aug 25;270(8):943-7.PMID: 8141873 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma.

    Brindle JS, Shaw EG, Su JQ, Mailliard JA, Frank AR, Laurie JA, McLean M, Tackett DM, Owens DT.

    Cancer. 1993 Jul 15;72(2):405-9.PMID: 8391378 [PubMed - indexed for MEDLINE]Related articles

    14.

    Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.

    Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE.

    Cancer. 1992 Mar 15;69(6):1440-4.PMID: 1540881 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.

    LONG HJ 3rd, Wieand HS, Foley JF, Niedringhaus RD, Laurie JA, Morton RF, Goldberg RM, Mailliard JA, Malkasian GD, Edmonson JH.

    Invest New Drugs. 1991 Nov;9(4):349-51.PMID: 1839536 [PubMed - indexed for MEDLINE]Related articles

    16.

    A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.

    Long HJ 3rd, Laurie JA, Wieand HS, Edmonson JH, Levitt R, Krook JE, Abu-Ghazaleh S.

    Cancer. 1991 Aug 15;68(4):730-2.PMID: 1830238 [PubMed - indexed for MEDLINE]Related articles

    17.

    A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.

    Windschitl HE, O'Connell MJ, Wieand HS, Krook JE, Rubin J, Moertel CG, Kugler JW, Pfeifle DM, Goldberg RM, Laurie JA.

    Cancer. 1990 Sep 1;66(5):853-6.PMID: 2201430 [PubMed - indexed for MEDLINE]Related articles

    18.

    Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

    Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al.

    N Engl J Med. 1990 Feb 8;322(6):352-8.PMID: 2300087 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens.

    Edmonson JH, McCormack GM, Wieand HS, Kugler JW, Krook JE, Stanhope CR, Everson LK, Laurie JA, Ebbert LP, Malkasian GD, et al.

    J Natl Cancer Inst. 1989 Oct 4;81(19):1500-4.PMID: 2674460 [PubMed - indexed for MEDLINE]Related articles

    20.

    Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J, et al.

    J Clin Oncol. 1989 Oct;7(10):1447-56.PMID: 2778478 [PubMed - indexed for MEDLINE]Related articles

    21.

    Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

    Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK, et al.

    J Clin Oncol. 1989 Oct;7(10):1407-18. Review.PMID: 2476530 [PubMed - indexed for MEDLINE]Related articles

    22.

    Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma.

    Marschke RF Jr, Kvols LK, Cullinan SA, Laurie JA, Mailliard JA, Tschetter LK, O'Connell MJ.

    Med Pediatr Oncol. 1988;16(4):269-70.PMID: 3419393 [PubMed - indexed for MEDLINE]Related articles

    23.

    Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.

    Morton RF, Creagan ET, Veeder MH, Elson DL, Laurie JA, Nelimark RA, Chang MN.

    Cancer Treat Rep. 1987 Apr;71(4):429-30. No abstract available. PMID: 3548962 [PubMed - indexed for MEDLINE]Related articles

    24.

    A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.

    Buroker TR, Moertel CG, Fleming TR, Everson LK, Cullinan SA, Krook JE, Mailliard JA, Marschke RF, Klaassen DJ, Laurie JA, et al.

    J Clin Oncol. 1985 Dec;3(12):1624-31.PMID: 2933492 [PubMed - indexed for MEDLINE]Related articles

    25.

    Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure.

    Ingle JN, Pfeifle DM, Green SJ, Kvols LK, Brunk SF, Reuter NF, Krook JE, Laurie JA, Everson LK, Marschke RF, et al.

    Am J Clin Oncol. 1985 Aug;8(4):275-82.PMID: 3909798 [PubMed - indexed for MEDLINE]Related articles

    26.

    A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.

    Krook JE, Jett JR, Fleming TR, Dalton RJ, Marschke RF, Cullinan SA, Windschitl HE, Everson LK, Brunk FS, Laurie JA, et al.

    J Clin Oncol. 1985 Jun;3(6):842-8.PMID: 3839263 [PubMed - indexed for MEDLINE]Related articles

    27.

    Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.

    Krook JE, Ingle JN, Green SJ, Bowman WD, Everson LK, Windschitl HE, Marschke RF, Laurie JA, Cullinan SA, Pfeifle DM, et al.

    Cancer Treat Rep. 1985 Apr;69(4):355-61.PMID: 3888386 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...